carbachol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marino, MJ | 1 |
Rouse, ST | 1 |
Levey, AI | 1 |
Potter, LT | 1 |
Conn, PJ | 1 |
Sherer, TB | 1 |
Trimmer, PA | 1 |
Parks, JK | 1 |
Tuttle, JB | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Muscarinic M1 Receptor Availability and Cognition in Schizophrenia[NCT05105542] | Phase 2 | 18 participants (Anticipated) | Interventional | 2021-04-20 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for carbachol and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.
Topics: Animals; Carbachol; Elapid Venoms; Electrophysiology; Hippocampus; Male; Microscopy, Immunoelectron; | 1998 |
Mitochondrial DNA-depleted neuroblastoma (Rho degrees) cells exhibit altered calcium signaling.
Topics: Calcium; Calcium Signaling; Carbachol; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cytologic | 2000 |